1009071-34-4

Basic information

• Product Name: 1-Boc-3-Methylpyrazole-4-boronic acid pinacol ester
• Synonyms: 1-Boc-3-Methylpyrazole-4-boronic acid pinacol ester;tert-butyl 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate
• CAS NO: 1009071-34-4
• Molecular Formula: C₁₅H₂₅BN₂O₄
• Molecular Weight: 326.19628
• Mol File: 1009071-34-4.mol

Chemical Properties

• Boiling Point: 404.9±47.0 °C(Predicted)
• Appearance: /
• Density: 1.08±0.1 g/cm3(Predicted)
• PKA: -0.49±0.12(Predicted)
• CAS DataBase Reference: 1-Boc-3-Methylpyrazole-4-boronic acid pinacol ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Boc-3-Methylpyrazole-4-boronic acid pinacol ester(1009071-34-4)
• EPA Substance Registry System: 1-Boc-3-Methylpyrazole-4-boronic acid pinacol ester(1009071-34-4)

Safety Data

• Hazardous Substances Data: 1009071-34-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
1-Boc-3-Methylpyrazole-4-boronic acid pinacol ester is employed as a reagent in the synthesis of pharmaceuticals, leveraging its capacity to form new bonds with nucleophiles. This property is crucial for the development of novel drug molecules and the modification of existing ones to enhance their therapeutic efficacy and pharmacokinetic profiles.
Used in Organic Molecule Synthesis:
In the broader field of organic chemistry, 1-Boc-3-Methylpyrazole-4-boronic acid pinacol ester is used as a versatile building block for the creation of complex organic molecules. Its reactivity with nucleophiles allows for the construction of diverse molecular architectures, which can be applied across various chemical and material science applications.
Used in Research and Development:
1-Boc-3-Methylpyrazole-4-boronic acid pinacol ester is also utilized in research and development settings, where its unique reactivity is harnessed to explore new chemical reactions and mechanisms. This can lead to the discovery of innovative synthetic pathways and the optimization of existing ones, ultimately contributing to advancements in the field of organic synthesis.
Used in Chemical Industry:
Within the chemical industry, 1-Boc-3-Methylpyrazole-4-boronic acid pinacol ester is employed as a key intermediate in the production of specialty chemicals, agrochemicals, and other fine chemicals. Its ability to form new bonds with nucleophiles makes it a valuable component in the synthesis of a wide range of chemical products.

Upstream product

• 936250-20-3 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1021919-24-3 tert-butyl 4-bromo-3-methyl-1H-pyrazole-1-carboxylate 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 1072709-38-6 6-[2-chloro-4-(3-methyl-1H-pyrazol-4-yl)phenyl]-5-(4-chlorophenyl)-2-(2,2-dimethylpropanoyl)furo[2,3-b]pyridine-3-carboxamide 
• 1330783-91-9 benzyl 1-{6-[1-(tert-butoxycarbonyl)-3-methyl-1H-pyrazol-4-yl]-4-oxo-3,4-dihydrothieno[3,2-d]pyrimidin-2-yl}-7-azabicyclo[2.2.1]heptane-7-carboxylate 
• 1330781-99-1 6-(5-methyl-1H-pyrazol-4-yl)-2-(2-phenyl-1-pyrrolidin-1-ylethyl)thieno[3,2-d]pyrimidin-4(3H)-one 

Relevant articles and documents

THIENOPYRIMIDINE AS CDC7 KINASE INHIBITORS

The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, or a prodrug thereof, which is useful for the prophylaxis or treatment of cancer

Substituted furo[2,3-B] pyridine derivatives as cannabinoid-1 receptor modulators

Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, Alzheimer's disease, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, cirrhosis of the liver, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and the promotion of wakefulness.

HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

Provided herein are Heteroaryl Compounds having the following structure: (I) wherein R1, R2, L, X, Y, Z, Q, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.